2,0
12. Juli 2024
Ehemaliger Mitarbeiter, mehr als 1 Jahr
Kuala Lumpur
Empfehlen
CEO-Befürwortung
Geschäftsprognose
Pros
-Good ground to gain experience in pharmaceutical industry. -EPF is high.
Kontras
Incentive scheme is lousy, people are promoted based on favouritism. Some youngsters who carry manager titles do not know how to lead.